Oligonucleotides for genotyping thymidylate synthase gene
Oligonucleotides for genotyping the thymidylate synthase gene are provided. The number of tandem repeats in the promoter region of the thymidylate synthase gene can be identified based on the hybridization of an oligonucleotide of the invention to the genomic DNA of a subject. Therefore, the genotype of the thymidylate synthase gene can be identified based on the number of tandem repeats. The genotype relates to the responsiveness of a subject towards an antitumor agent.
1. A kit for identifying the number of tandem repeats in the promoter region of a human thymidylate synthase gene, the kit comprising:
(a) a first oligonucleotide, the sequence of which consists of SEQ ID NO:1 or the exact complementary sequence thereof; and
(b) a second oligonucleotide, the sequence of which consists of SEQ ID NO:2 or the exact complementary sequence thereof.
2. The kit of claim 1 , wherein the downstream end of the second oligonucleotide is labeled with FITC, and the upstream end of the first oligonucleotide is labeled with the fluorescent dye RED640 or RED705.
3. A kit comprising
(a) a first oligonucleotide, the sequence of which consists of SEQ ID NO:1 or the exact complement thereof; and
(b) a second oligonucleotide, the sequence of which consists of SEQ ID NO:2 or the exact complement thereof,
each of the oligonucleotides being optionally labeled with a fluorescent dye.
4. An isolated oligonucleotide, the sequence of which consists of SEQ ID NO:2.
5. The oligonucleotide of claim 4 , wherein the oligonucleotide is labeled with a detectable label.
6. The kit of claim 2 , wherein the upstream end of the first oligonucleotide is labeled with the fluorescent dye RED705.
7. The kit of claim 1 , wherein the sequence of the first oligonucleotide consists of SEQ ID NO:1 and the sequence of the second oligonucleotide consists of SEQ ID NO:2.
8. The kit of claim 1 , wherein the sequence of the first oligonucleotide consists of the exact complement of SEQ ID NO:1 and the sequence of the second oligonucleotide consists of the exact complement of SEQ ID NO:2.
9. The kit of claim 3 , wherein the sequence of the first oligonucleotide consists of SEQ ID NO:1 and the sequence of the second oligonucleotide consists of SEQ ID NO:2.
10. The kit of claim 3 , wherein the sequence of the first oligonucleotide consists of the exact complement of SEQ ID NO:1 and the sequence of the second oligonucleotide consists of the exact complement of SEQ ID NO:2.